Enliven Therapeutics, Inc. <ELVN.O>: Baird Assumes Coverage With Outperform Rating; Target Price $75
ELVN•Related News
HII cites new shipyard labor deals with wage hikes to retain skilled workforce
HII•
PrimeEnergy Resources director Clint Hurt disposes of USD 398,736 common shares
PNRG•
Nasdaq trade halt continues <BRTX.O> halt news pending at 03:28 AM
BRTX•
Nasdaq Trade Halt <TNMG.O> Halt News Pending at 07:50 PM
TNMG•
Nasdaq Trade Halt <BRTX.O> Halt News Pending at 07:50 PM
BRTX•